Symbols / OPRX Stock $6.41 -5.74% OptimizeRx Corporation
OPRX (Stock) Chart
About
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.
Stock Fundamentals
Scroll to Statements| Market Cap | 120.27M | Enterprise Value | 130.32M | Income | 5.13M | Sales | 109.43M | Book/sh | 6.84 | Cash/sh | 1.25 |
| Dividend Yield | — | Payout | 0.00% | Employees | 132 | IPO | — | P/E | 23.74 | Forward P/E | 5.75 |
| PEG | 1.61 | P/S | 1.10 | P/B | 0.94 | P/C | — | EV/EBITDA | 7.95 | EV/Sales | 1.19 |
| Quick Ratio | 2.91 | Current Ratio | 3.04 | Debt/Eq | 20.35 | LT Debt/Eq | — | EPS (ttm) | 0.27 | EPS next Y | 1.11 |
| EPS Growth | — | Revenue Growth | -0.20% | Earnings | 2026-05-12 | ROA | 4.33% | ROE | 4.18% | ROIC | — |
| Gross Margin | 67.25% | Oper. Margin | 27.72% | Profit Margin | 4.69% | Shs Outstand | 18.76M | Shs Float | 14.48M | Short Float | 11.23% |
| Short Ratio | 3.53 | Short Interest | — | 52W High | 22.25 | 52W Low | 5.54 | Beta | 1.28 | Avg Volume | 500.61K |
| Volume | 384.03K | Target Price | $14.50 | Recom | None | Prev Close | $6.80 | Price | $6.41 | Change | -5.74% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-06 | main | Lake Street | Buy → Buy | $20 |
| 2026-03-06 | main | Roth Capital | Buy → Buy | $18 |
| 2026-03-06 | reit | B. Riley Securities | Buy → Buy | $11 |
| 2026-03-06 | main | Stephens & Co. | Equal-Weight → Equal-Weight | $10 |
| 2026-03-06 | main | Stifel | Buy → Buy | $17 |
| 2025-11-17 | main | Stephens & Co. | Equal-Weight → Equal-Weight | $17 |
| 2025-11-07 | main | Citizens | Market Outperform → Market Outperform | $24 |
| 2025-10-10 | main | JMP Securities | Market Outperform → Market Outperform | $23 |
| 2025-08-11 | main | JMP Securities | Market Outperform → Market Outperform | $20 |
| 2025-08-08 | main | Stifel | Buy → Buy | $18 |
| 2025-06-09 | main | Stifel | Buy → Buy | $16 |
| 2025-05-13 | main | Stifel | Buy → Buy | $13 |
| 2025-05-13 | main | JMP Securities | Market Outperform → Market Outperform | $14 |
| 2025-02-06 | reit | JMP Securities | Market Outperform → Market Outperform | $8 |
| 2025-01-08 | down | RBC Capital | Outperform → Sector Perform | $6 |
| 2024-12-24 | reit | Lake Street | Buy → Buy | $11 |
| 2024-12-24 | main | B. Riley Securities | Buy → Buy | $13 |
| 2024-12-20 | init | Stephens & Co. | — → Equal-Weight | $6 |
| 2024-11-14 | main | RBC Capital | Outperform → Outperform | $7 |
| 2024-11-14 | reit | Roth MKM | Buy → Buy | $16 |
- OptimizeRx (OPRX) soars 5.9%: Is further upside left in the stock? - MSN hu, 23 Apr 2026 16
- Is OptimizeRx (OPRX) Stock Undervalued Right Now? - Yahoo Finance Mon, 16 Mar 2026 07
- Will Enterprise Deals & MedTech Momentum Fuel OPRX's Growth Engine? - TradingView hu, 23 Apr 2026 13
- OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat hu, 23 Apr 2026 08
- OptimizeRx Corporation (OPRX) Stock Hits 52-Week High (Weakens) 2026-04-20 - Low Volatility Stocks - Cổng thông tin điện tử tỉnh Lào Cai ue, 21 Apr 2026 03
- New OptimizeRx Corp (OPRX) director registers insider status with Form 3 - Stock Titan Wed, 22 Apr 2026 14
- Will Enterprise Deals & MedTech Momentum Fuel OPRX's Growth Engine? - Zacks Investment Research hu, 23 Apr 2026 12
- $OPRX stock is down 10% today. Here's what we see in our data. - Quiver Quantitative ue, 13 Jan 2026 08
- Should Value Investors Buy OptimizeRx (OPRX) Stock? - Yahoo Finance Fri, 17 Apr 2026 13
- From loss to profit: OptimizeRx posts record $109.4M sales and $10M buyback - Stock Titan hu, 05 Mar 2026 08
- $OPRX stock is down 20% today. Here's what we see in our data. - Quiver Quantitative Fri, 07 Nov 2025 08
- OPRX Trades at a Discount to Industry: How to Approach the Stock Now? - Zacks Investment Research Fri, 17 Apr 2026 14
- Can OptimizeRx's Cash Strength Cushion Near-Term Headwinds? - TradingView ue, 21 Apr 2026 14
- Microsoft Health COO joins OptimizeRx board in director refresh - Stock Titan Wed, 08 Apr 2026 07
- OptimizeRx (OPRX) Price Target Increased by 24.79% to 24.82 - MSN ue, 21 Apr 2026 13
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
109.43
+18.78%
|
92.13
+28.81%
|
71.52
+14.53%
|
62.45
|
| Operating Revenue |
|
109.43
+18.78%
|
92.13
+28.81%
|
71.52
+14.53%
|
62.45
|
| Cost Of Revenue |
|
35.83
+9.42%
|
32.75
+14.42%
|
28.62
+21.88%
|
23.48
|
| Reconciled Cost Of Revenue |
|
35.83
+9.42%
|
32.75
+14.42%
|
28.62
+21.88%
|
23.48
|
| Gross Profit |
|
73.59
+23.94%
|
59.38
+38.41%
|
42.90
+10.09%
|
38.97
|
| Operating Expense |
|
61.53
-6.19%
|
65.59
+8.56%
|
60.42
+17.88%
|
51.26
|
| Selling General And Administration |
|
57.21
-6.63%
|
61.27
+5.59%
|
58.02
+17.84%
|
49.24
|
| Selling And Marketing Expense |
|
—
|
—
|
—
|
—
|
| General And Administrative Expense |
|
57.21
-6.63%
|
61.27
+5.59%
|
58.02
+17.84%
|
49.24
|
| Salaries And Wages |
|
6.96
-39.29%
|
11.47
-16.40%
|
13.72
-12.88%
|
15.75
|
| Other Gand A |
|
50.24
+0.90%
|
49.80
+12.41%
|
44.30
+32.29%
|
33.49
|
| Other Operating Expenses |
|
—
|
—
|
—
|
—
|
| Total Expenses |
|
97.37
-0.99%
|
98.34
+10.44%
|
89.04
+19.14%
|
74.74
|
| Operating Income |
|
12.06
+294.00%
|
-6.22
+64.52%
|
-17.52
-42.56%
|
-12.29
|
| Total Operating Income As Reported |
|
11.69
+185.31%
|
-13.71
+48.09%
|
-26.40
-114.81%
|
-12.29
|
| EBITDA |
|
16.57
+286.27%
|
-8.90
+58.25%
|
-21.31
-126.29%
|
-9.42
|
| Normalized EBITDA |
|
16.94
+1303.91%
|
-1.41
+88.68%
|
-12.43
-31.98%
|
-9.42
|
| Reconciled Depreciation |
|
4.33
-0.05%
|
4.33
+80.22%
|
2.40
+18.79%
|
2.02
|
| EBIT |
|
12.24
+192.58%
|
-13.22
+44.22%
|
-23.71
-107.28%
|
-11.44
|
| Total Unusual Items |
|
-0.37
+95.09%
|
-7.49
+15.66%
|
-8.88
|
0.00
|
| Total Unusual Items Excluding Goodwill |
|
-0.37
+95.09%
|
-7.49
+15.66%
|
-8.88
|
0.00
|
| Special Income Charges |
|
-0.37
+95.09%
|
-7.49
+15.66%
|
-8.88
|
0.00
|
| Impairment Of Capital Assets |
|
0.37
-95.09%
|
7.49
+11.15%
|
6.74
|
0.00
|
| Restructuring And Mergern Acquisition |
|
—
|
—
|
—
|
—
|
| Net Income |
|
5.13
+125.52%
|
-20.11
-14.48%
|
-17.57
-53.57%
|
-11.44
|
| Pretax Income |
|
6.95
+135.85%
|
-19.39
+22.97%
|
-25.16
-120.00%
|
-11.44
|
| Net Non Operating Interest Income Expense |
|
-4.94
+15.26%
|
-5.83
-890.11%
|
0.74
-13.41%
|
0.85
|
| Interest Expense Non Operating |
|
5.29
-14.06%
|
6.16
+323.66%
|
1.45
|
0.00
|
| Net Interest Income |
|
-4.94
+15.26%
|
-5.83
-890.11%
|
0.74
-13.41%
|
0.85
|
| Interest Expense |
|
5.29
-14.06%
|
6.16
+323.66%
|
1.45
|
0.00
|
| Interest Income Non Operating |
|
0.35
+7.29%
|
0.33
-84.99%
|
2.19
+157.19%
|
0.85
|
| Interest Income |
|
0.35
+7.29%
|
0.33
-84.99%
|
2.19
+157.19%
|
0.85
|
| Other Income Expense |
|
-0.17
+97.68%
|
-7.34
+12.45%
|
-8.38
|
—
|
| Other Non Operating Income Expenses |
|
0.20
+30.26%
|
0.15
-69.60%
|
0.50
|
—
|
| Gain On Sale Of Business |
|
—
|
0.00
+100.00%
|
-2.14
|
0.00
|
| Tax Provision |
|
1.82
+150.76%
|
0.72
+109.54%
|
-7.60
|
0.00
|
| Tax Rate For Calcs |
|
0.00
+24.76%
|
0.00
-30.45%
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.10
+93.87%
|
-1.57
+41.34%
|
-2.68
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
5.13
+125.52%
|
-20.11
-14.48%
|
-17.57
-53.57%
|
-11.44
|
| Net Income From Continuing Operation Net Minority Interest |
|
5.13
+125.52%
|
-20.11
-14.48%
|
-17.57
-53.57%
|
-11.44
|
| Net Income From Continuing And Discontinued Operation |
|
5.13
+125.52%
|
-20.11
-14.48%
|
-17.57
-53.57%
|
-11.44
|
| Net Income Continuous Operations |
|
5.13
+125.52%
|
-20.11
-14.48%
|
-17.57
-53.57%
|
-11.44
|
| Normalized Income |
|
5.40
+138.07%
|
-14.19
-24.87%
|
-11.37
+0.62%
|
-11.44
|
| Net Income Common Stockholders |
|
5.13
+125.52%
|
-20.11
-14.48%
|
-17.57
-53.57%
|
-11.44
|
| Diluted EPS |
|
0.27
+124.55%
|
-1.10
-6.80%
|
-1.03
-60.94%
|
-0.64
|
| Basic EPS |
|
0.28
+125.45%
|
-1.10
-6.80%
|
-1.03
-60.94%
|
-0.64
|
| Basic Average Shares |
|
18.56
+1.43%
|
18.29
+6.82%
|
17.12
-3.71%
|
17.78
|
| Diluted Average Shares |
|
19.00
+3.86%
|
18.29
+6.82%
|
17.12
-3.71%
|
17.78
|
| Diluted NI Availto Com Stockholders |
|
5.13
+125.52%
|
-20.11
-14.48%
|
-17.57
-53.57%
|
-11.44
|
| Average Dilution Earnings |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Depreciation Amortization Depletion Income Statement |
|
4.33
-0.05%
|
4.33
+80.22%
|
2.40
+18.79%
|
2.02
|
| Depreciation And Amortization In Income Statement |
|
4.33
-0.05%
|
4.33
+80.22%
|
2.40
+18.79%
|
2.02
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
176.92
+3.36%
|
171.17
-6.66%
|
183.37
+36.18%
|
134.65
|
| Current Assets |
|
64.72
+19.91%
|
53.97
-0.66%
|
54.33
-44.88%
|
98.58
|
| Cash Cash Equivalents And Short Term Investments |
|
23.36
+74.63%
|
13.38
-3.41%
|
13.85
-81.32%
|
74.14
|
| Cash And Cash Equivalents |
|
23.36
+74.63%
|
13.38
-3.41%
|
13.85
-23.93%
|
18.21
|
| Other Short Term Investments |
|
—
|
—
|
0.00
-100.00%
|
55.93
|
| Receivables |
|
38.50
+0.76%
|
38.21
+2.48%
|
37.29
+68.31%
|
22.16
|
| Accounts Receivable |
|
37.75
-1.20%
|
38.21
+5.40%
|
36.25
+63.63%
|
22.16
|
| Gross Accounts Receivable |
|
38.01
-1.39%
|
38.55
+5.63%
|
36.49
+62.13%
|
22.51
|
| Allowance For Doubtful Accounts Receivable |
|
-0.26
+22.39%
|
-0.34
-40.17%
|
-0.24
+32.11%
|
-0.35
|
| Taxes Receivable |
|
0.75
|
0.00
-100.00%
|
1.04
|
0.00
|
| Prepaid Assets |
|
2.33
+9.53%
|
2.13
-23.48%
|
2.79
+54.11%
|
1.81
|
| Other Current Assets |
|
0.51
+106.45%
|
0.25
-38.77%
|
0.41
-14.49%
|
0.47
|
| Total Non Current Assets |
|
112.20
-4.26%
|
117.20
-9.18%
|
129.04
+257.71%
|
36.07
|
| Net PPE |
|
0.51
-1.16%
|
0.52
-28.53%
|
0.72
+93.69%
|
0.37
|
| Gross PPE |
|
0.86
+11.24%
|
0.77
-11.34%
|
0.87
+73.12%
|
0.50
|
| Accumulated Depreciation |
|
-0.35
-36.05%
|
-0.26
-70.86%
|
-0.15
-14.81%
|
-0.13
|
| Machinery Furniture Equipment |
|
0.46
+12.01%
|
0.41
+36.00%
|
0.30
+11.54%
|
0.27
|
| Other Properties |
|
0.40
+10.38%
|
0.37
-36.13%
|
0.57
+143.50%
|
0.24
|
| Goodwill And Other Intangible Assets |
|
111.67
-4.06%
|
116.39
-8.90%
|
127.75
+257.88%
|
35.70
|
| Goodwill |
|
70.87
+0.00%
|
70.87
-9.56%
|
78.36
+245.58%
|
22.67
|
| Other Intangible Assets |
|
40.80
-10.37%
|
45.52
-7.85%
|
49.40
+279.30%
|
13.02
|
| Other Non Current Assets |
|
0.03
-90.54%
|
0.30
-47.89%
|
0.57
+11145.30%
|
0.01
|
| Total Liabilities Net Minority Interest |
|
48.62
-10.24%
|
54.17
-4.67%
|
56.82
+565.32%
|
8.54
|
| Current Liabilities |
|
21.26
+13.99%
|
18.65
+4.32%
|
17.88
+112.99%
|
8.40
|
| Payables And Accrued Expenses |
|
16.31
+1.87%
|
16.01
+3.39%
|
15.49
+90.23%
|
8.14
|
| Payables |
|
4.72
-37.27%
|
7.53
-3.28%
|
7.78
+40.46%
|
5.54
|
| Accounts Payable |
|
1.64
-24.12%
|
2.16
-3.19%
|
2.23
+43.68%
|
1.55
|
| Other Payable |
|
3.09
-38.93%
|
5.05
-8.23%
|
5.51
+37.98%
|
3.99
|
| Current Accrued Expenses |
|
11.59
+36.59%
|
8.49
+10.12%
|
7.71
+196.24%
|
2.60
|
| Total Tax Payable |
|
0.00
-100.00%
|
0.32
+548.98%
|
0.05
|
—
|
| Current Debt And Capital Lease Obligation |
|
4.45
+105.17%
|
2.17
-2.43%
|
2.22
+2371.58%
|
0.09
|
| Current Debt |
|
4.25
+112.75%
|
2.00
+0.00%
|
2.00
|
—
|
| Other Current Borrowings |
|
4.25
+112.75%
|
2.00
+0.00%
|
2.00
|
—
|
| Current Capital Lease Obligation |
|
0.19
+14.88%
|
0.17
-24.32%
|
0.22
+146.94%
|
0.09
|
| Current Deferred Liabilities |
|
0.50
+6.34%
|
0.47
+175.00%
|
0.17
+4.68%
|
0.16
|
| Current Deferred Revenue |
|
0.50
+6.34%
|
0.47
+175.00%
|
0.17
+4.68%
|
0.16
|
| Total Non Current Liabilities Net Minority Interest |
|
27.36
-22.96%
|
35.52
-8.79%
|
38.94
+26841.44%
|
0.14
|
| Long Term Debt And Capital Lease Obligation |
|
21.66
-30.20%
|
31.02
-10.34%
|
34.60
+23840.72%
|
0.14
|
| Long Term Debt |
|
21.42
-30.49%
|
30.82
-9.98%
|
34.23
|
—
|
| Long Term Capital Lease Obligation |
|
0.23
+11.96%
|
0.21
-43.67%
|
0.37
+156.69%
|
0.14
|
| Non Current Deferred Liabilities |
|
5.71
+27.03%
|
4.49
+3.55%
|
4.34
|
0.00
|
| Non Current Deferred Taxes Liabilities |
|
5.71
+27.03%
|
4.49
+3.55%
|
4.34
|
0.00
|
| Stockholders Equity |
|
128.29
+9.65%
|
117.00
-7.55%
|
126.55
+0.35%
|
126.11
|
| Common Stock Equity |
|
128.29
+9.65%
|
117.00
-7.55%
|
126.55
+0.35%
|
126.11
|
| Capital Stock |
|
0.02
+0.00%
|
0.02
+0.00%
|
0.02
+9.36%
|
0.02
|
| Common Stock |
|
0.02
+0.00%
|
0.02
+0.00%
|
0.02
+9.36%
|
0.02
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
20.50
+1.52%
|
20.19
+1.48%
|
19.90
+8.81%
|
18.29
|
| Ordinary Shares Number |
|
18.76
+1.66%
|
18.45
+1.62%
|
18.16
+6.35%
|
17.07
|
| Treasury Shares Number |
|
1.74
+0.00%
|
1.74
+0.00%
|
1.74
+43.40%
|
1.21
|
| Additional Paid In Capital |
|
207.51
+3.06%
|
201.35
+5.53%
|
190.79
+10.42%
|
172.79
|
| Retained Earnings |
|
-79.24
+6.08%
|
-84.37
-31.30%
|
-64.26
-37.62%
|
-46.69
|
| Treasury Stock |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+64.74%
|
0.00
|
| Total Equity Gross Minority Interest |
|
128.29
+9.65%
|
117.00
-7.55%
|
126.55
+0.35%
|
126.11
|
| Total Capitalization |
|
149.72
+1.29%
|
147.81
-8.07%
|
160.78
+27.49%
|
126.11
|
| Working Capital |
|
43.45
+23.03%
|
35.32
-3.11%
|
36.45
-59.58%
|
90.18
|
| Invested Capital |
|
153.97
+2.77%
|
149.81
-7.97%
|
162.78
+29.08%
|
126.11
|
| Total Debt |
|
26.10
-21.36%
|
33.19
-9.86%
|
36.82
+15607.62%
|
0.23
|
| Net Debt |
|
2.31
-88.11%
|
19.44
-13.15%
|
22.38
|
—
|
| Capital Lease Obligations |
|
0.43
+13.26%
|
0.38
-36.42%
|
0.59
+152.95%
|
0.23
|
| Net Tangible Assets |
|
16.63
+2612.72%
|
0.61
+151.08%
|
-1.20
-101.33%
|
90.41
|
| Tangible Book Value |
|
16.63
+2612.72%
|
0.61
+151.08%
|
-1.20
-101.33%
|
90.41
|
| Preferred Shares Number |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
18.71
+282.80%
|
4.89
+167.53%
|
-7.24
-167.96%
|
10.65
|
| Cash Flow From Continuing Operating Activities |
|
18.71
+282.80%
|
4.89
+167.53%
|
-7.24
-167.96%
|
10.65
|
| Net Income From Continuing Operations |
|
5.13
+125.52%
|
-20.11
-14.48%
|
-17.57
-53.57%
|
-11.44
|
| Depreciation Amortization Depletion |
|
4.33
-0.05%
|
4.33
+80.22%
|
2.40
+18.79%
|
2.02
|
| Depreciation |
|
0.10
-8.11%
|
0.11
+11.00%
|
0.10
+16.65%
|
0.09
|
| Amortization Cash Flow |
|
4.22
+0.17%
|
4.22
+83.23%
|
2.30
+18.89%
|
1.94
|
| Depreciation And Amortization |
|
4.33
-0.05%
|
4.33
+80.22%
|
2.40
+18.79%
|
2.02
|
| Amortization Of Intangibles |
|
4.22
+0.17%
|
4.22
+83.23%
|
2.30
+18.89%
|
1.94
|
| Other Non Cash Items |
|
1.11
+32.93%
|
0.83
+295.73%
|
0.21
|
—
|
| Stock Based Compensation |
|
6.96
-39.29%
|
11.47
-16.40%
|
13.72
-12.88%
|
15.75
|
| Provisionand Write Offof Assets |
|
—
|
—
|
—
|
0.36
|
| Asset Impairment Charge |
|
0.37
-95.22%
|
7.70
+3.96%
|
7.40
+1936.80%
|
0.36
|
| Operating Gains Losses |
|
—
|
—
|
2.14
|
—
|
| Change In Working Capital |
|
0.82
+21.61%
|
0.67
+104.32%
|
-15.55
-492.56%
|
3.96
|
| Change In Receivables |
|
0.46
+121.22%
|
-2.17
+75.12%
|
-8.71
-481.85%
|
2.28
|
| Changes In Account Receivables |
|
0.46
+121.22%
|
-2.17
+75.12%
|
-8.71
-481.85%
|
2.28
|
| Change In Prepaid Assets |
|
-0.47
-157.58%
|
0.81
+241.54%
|
-0.57
-121.61%
|
2.65
|
| Change In Payables And Accrued Expense |
|
0.89
+67.99%
|
0.53
-64.75%
|
1.50
+489.70%
|
0.25
|
| Change In Accrued Expense |
|
3.37
+220.42%
|
1.05
-19.19%
|
1.30
+532.36%
|
-0.30
|
| Change In Payable |
|
-2.49
-373.71%
|
-0.53
-369.23%
|
0.20
-64.89%
|
0.56
|
| Change In Account Payable |
|
-2.49
-373.71%
|
-0.53
-369.23%
|
0.20
-64.89%
|
0.56
|
| Change In Other Working Capital |
|
-0.08
-105.07%
|
1.50
+119.32%
|
-7.76
-533.32%
|
-1.23
|
| Change In Other Current Liabilities |
|
0.01
|
0.00
|
—
|
0.00
|
| Investing Cash Flow |
|
0.07
+115.11%
|
-0.45
+98.22%
|
-25.34
+56.45%
|
-58.18
|
| Cash Flow From Continuing Investing Activities |
|
0.07
+115.11%
|
-0.45
+98.22%
|
-25.34
+56.45%
|
-58.18
|
| Net PPE Purchase And Sale |
|
-0.06
+48.21%
|
-0.11
-45.45%
|
-0.08
+4.94%
|
-0.08
|
| Purchase Of PPE |
|
-0.06
+48.21%
|
-0.11
-28.74%
|
-0.09
-7.40%
|
-0.08
|
| Sale Of PPE |
|
—
|
0.00
-100.00%
|
0.01
|
0.00
|
| Capital Expenditure |
|
—
|
-0.45
+48.34%
|
-0.87
-256.14%
|
-0.24
|
| Capital Expenditure Reported |
|
0.13
+137.28%
|
-0.34
+56.89%
|
-0.78
-379.33%
|
-0.16
|
| Net Investment Purchase And Sale |
|
—
|
0.00
-100.00%
|
55.93
+200.00%
|
-55.93
|
| Purchase Of Investment |
|
—
|
0.00
+100.00%
|
-162.78
-191.03%
|
-55.93
|
| Sale Of Investment |
|
—
|
0.00
-100.00%
|
218.71
|
0.00
|
| Net Business Purchase And Sale |
|
—
|
0.00
+100.00%
|
-80.41
-3920.35%
|
-2.00
|
| Purchase Of Business |
|
—
|
0.00
+100.00%
|
-82.95
-4047.35%
|
-2.00
|
| Gain Loss On Sale Of Business |
|
—
|
0.00
-100.00%
|
2.14
|
0.00
|
| Net Intangibles Purchase And Sale |
|
—
|
—
|
—
|
-0.00
|
| Purchase Of Intangibles |
|
—
|
—
|
—
|
-0.00
|
| Financing Cash Flow |
|
-8.80
-79.15%
|
-4.91
-117.40%
|
28.22
+248.91%
|
-18.95
|
| Cash Flow From Continuing Financing Activities |
|
-8.80
-79.15%
|
-4.91
-117.40%
|
28.22
+248.91%
|
-18.95
|
| Net Issuance Payments Of Debt |
|
-8.00
-100.00%
|
-4.00
-111.10%
|
36.02
|
0.00
|
| Issuance Of Debt |
|
—
|
0.00
-100.00%
|
37.73
|
0.00
|
| Repayment Of Debt |
|
-8.00
-100.00%
|
-4.00
-133.92%
|
-1.71
|
0.00
|
| Long Term Debt Issuance |
|
—
|
0.00
-100.00%
|
37.73
|
0.00
|
| Long Term Debt Payments |
|
-8.00
-100.00%
|
-4.00
-133.92%
|
-1.71
|
0.00
|
| Net Long Term Debt Issuance |
|
-8.00
-100.00%
|
-4.00
-111.10%
|
36.02
|
0.00
|
| Net Common Stock Issuance |
|
—
|
0.00
+100.00%
|
-7.52
+62.44%
|
-20.02
|
| Common Stock Payments |
|
—
|
0.00
+100.00%
|
-7.52
+62.44%
|
-20.02
|
| Repurchase Of Capital Stock |
|
—
|
0.00
+100.00%
|
-7.52
+62.44%
|
-20.02
|
| Proceeds From Stock Option Exercised |
|
0.35
|
0.00
+100.00%
|
-0.28
-125.90%
|
1.07
|
| Net Other Financing Charges |
|
-1.15
-26.23%
|
-0.91
|
—
|
—
|
| Changes In Cash |
|
9.98
+2215.47%
|
-0.47
+89.17%
|
-4.36
+93.45%
|
-66.47
|
| Beginning Cash Position |
|
13.38
-3.41%
|
13.85
-23.93%
|
18.21
-78.50%
|
84.68
|
| End Cash Position |
|
23.36
+74.63%
|
13.38
-3.41%
|
13.85
-23.93%
|
18.21
|
| Free Cash Flow |
|
18.71
+321.60%
|
4.44
+154.73%
|
-8.11
-177.92%
|
10.41
|
| Interest Paid Supplemental Data |
|
4.18
-32.55%
|
6.20
+411.38%
|
1.21
|
0.00
|
| Income Tax Paid Supplemental Data |
|
1.76
+993.17%
|
0.16
+235.42%
|
0.05
|
0.00
|
| Common Stock Issuance |
|
—
|
—
|
—
|
0.00
|
| Issuance Of Capital Stock |
|
—
|
—
|
—
|
0.00
|
| Sale Of Business |
|
—
|
0.00
-100.00%
|
2.54
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-09 View
- 8-K2026-03-30 View
- 10-K2026-03-12 View
- 8-K2026-03-05 View
- 42026-02-13 View
- 42025-12-23 View
- 42025-12-23 View
- 42025-12-23 View
- 42025-12-23 View
- 42025-12-23 View
- 42025-12-22 View
- 42025-12-22 View
- 42025-12-22 View
- 42025-12-22 View
- 42025-12-22 View
- 42025-12-22 View
- 42025-12-15 View
- 42025-12-15 View
- 42025-11-10 View
- 42025-11-07 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|